Piperacillin and Tazobactam
Active substance: PIPERACILLIN SODIUM, TAZOBACTAM SODIUM
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · PIPERACILLIN SODIUM 2 g/10mL, TAZOBACTAM SODIUM .25 g/10mL
United StatesActive
Marketing holder: Hospira, Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PIPERACILLIN SODIUM · 2 g/10mL
- TAZOBACTAM SODIUM · .25 g/10mL
Registration
- Registration number
- 0409-3383
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS, PARENTERAL
Sources
- product · openFDA NDC · 0409-3383 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0409-3383 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0409-3383 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0409-3383 · Verified 2026-10-09 · open in source